Zolmitriptan Tablet
Product Images NDC 27241-021

7 FDA label images from Ajanta Pharma Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 27241-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Zolmitriptan Str)

Structure (Zolmitriptan Str)
Chemical structure diagram of zolmitriptan, showing its molecular framework including indole and oxazolidinone components, along with dimethylaminopropyl side chain.*
FDA Label Image

Figure1 (Zolmitriptan Fig1)

Figure1 (Zolmitriptan Fig1)
A line graph showing the estimated probability of response over time from initial dose for Zolmitriptan tablets at 1 mg, 2.5 mg, and 5 mg doses compared to placebo. The x-axis represents time from initial dose (0 to 4 hours), and the y-axis shows the estimated probability of response as a percentage (0% to 100%). Multiple dose-response curves are plotted, indicating increased response probability over time.*
FDA Label Image

Figure2 (Zolmitriptan Fig 2)

Figure2 (Zolmitriptan Fig 2)
A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose, comparing placebo and zolmitriptan doses of 1 mg, 2.5 mg, and 5 mg. The x-axis represents time in hours, and the y-axis represents the estimated probability percentage.*
FDA Label Image

Blister (Zolmitriptan 2 5 mg Blister)

Blister (Zolmitriptan 2 5 mg Blister)
Blister card packaging label for Zolmitriptan 2.5 mg oral tablets by Ajanta Pharma USA Inc. The label shows multiple individual tablet compartments with the drug name, strength, and product information including protection instructions and manufacturer details. The packaging is designed for prescription use and features barcodes and lot/expiration date markings.*
FDA Label Image

2.5mg (Zolmitriptan 2 5 mg)

2.5mg (Zolmitriptan 2 5 mg)
The packaging label is for Zolmitriptan Tablets, USP, 2.5 mg strength, in a bottle containing 6 tablets. The label displays the product name prominently with dosage strength in a green oval, the NDC number 27241-021-68, and the indication that it is Rx Only. It includes storage instructions, manufacturer Ajanta Pharma Limited, India, and marketer Ajanta Pharma USA Inc., Bridgewater, NJ. The label also features a barcode and warnings about child safety and storage.*
FDA Label Image

5mg-blister (Zolmitriptan 5 mg Blister)

5mg-blister (Zolmitriptan 5 mg Blister)
Packaging label for Zolmitriptan tablet, USP, 5 mg strength. The label displays three sections with identical information including the product name, strength, and instructions to protect from light and moisture. It indicates the manufacturer as Ajanta Pharma Ltd., Product of India, with a barcode above the product details.*
FDA Label Image

5mg (Zolmitriptan 5 mg)

5mg (Zolmitriptan 5 mg)
Carton packaging label for Zolmitriptan Tablets USP 5 mg, containing 3 tablets. The label indicates the active ingredient Zolmitriptan with a strength of 5 mg per coated tablet. The product is manufactured by Ajanta Pharma Limited, India, and marketed by Ajanta Pharma USA Inc. The label includes dosage and storage information, warnings, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.